---
layout: default
title: Research
---

# Research Interests

My research program integrates computer science, machine learning, and domain expertise in pathology to develop intelligent systems for medical image analysis and cancer diagnostics.

## Main Research Areas

### 1. Deep Learning for Histopathology

The primary focus is on developing deep learning methods for automated analysis of histopathological images. Key contributions include:

- **Weakly Supervised Learning**: Developing models that can learn from limited annotations in large-scale pathology datasets
- **Attention Mechanisms**: Incorporating attention-based architectures to identify clinically relevant regions in whole slide images
- **Multi-instance Learning**: Addressing the challenge of analyzing gigapixel images through multiple instance learning frameworks

### 2. Digital Pathology and Whole Slide Imaging

Digital pathology has transformed how tissue samples are analyzed. Our work includes:

- **Whole Slide Image Analysis**: Creating efficient algorithms for analyzing gigapixel-resolution digital pathology images
- **Tissue Classification**: Automated classification of tissue types and identification of abnormal regions
- **Spatial Analysis**: Understanding spatial relationships and patterns within tissue samples

### 3. Cancer Detection and Classification

Applications of AI in cancer diagnosis form a significant part of our research:

- **Tumor Detection**: Identifying malignant lesions in histopathological images
- **Grading and Stratification**: Automated cancer grading systems for prognostic assessment
- **Biomarker Discovery**: Computational identification of prognostic and predictive biomarkers

### 4. Model Robustness and Domain Adaptation

Ensuring AI models work reliably in diverse clinical settings:

- **Domain Adaptation**: Addressing differences between training data and real-world clinical data
- **Model Validation**: Rigorous validation protocols across multiple datasets and institutions
- **Uncertainty Quantification**: Developing methods to estimate model confidence and uncertainty

### 5. Translational Pathology

Bridging the gap between research and clinical practice:

- **Clinical Integration**: Designing AI systems that integrate seamlessly into clinical workflows
- **Interpretability**: Creating explainable AI models that pathologists can trust and understand
- **Clinical Validation**: Conducting prospective studies to validate diagnostic accuracy

## Recent Projects

{% if site.projects.size > 0 %}

<div class="projects-grid">
{% for project in site.projects | sort: "date" | reverse %}
  <div class="project-item">
    <h3>{{ project.title }}</h3>
    {% if project.tags %}
    <div class="tags">
      {% for tag in project.tags %}
      <span class="tag">{{ tag }}</span>
      {% endfor %}
    </div>
    {% endif %}
    <p>{{ project.excerpt }}</p>
    {% if project.url %}
    <a href="{{ project.url | relative_url }}">Learn more →</a>
    {% endif %}
  </div>
{% endfor %}
</div>

{% endif %}

## Active Collaborations

We actively collaborate with:

- Clinical partners at [Hospital/Medical Center Names]
- Research groups at [University Names]
- Industry partners including [Company Names]

## Funding

Our research is supported by:

- [Funding Agency] - [Grant Title/Number]
- [Funding Agency] - [Grant Title/Number]
- [Funding Agency] - [Grant Title/Number]

## Research Methodology

We employ rigorous research methodologies including:

1. **Data Collection**: Curating large-scale datasets of histopathological images with expert annotations
2. **Model Development**: Implementing state-of-the-art deep learning architectures
3. **Validation and Evaluation**: Comprehensive evaluation using multiple metrics and test sets
4. **External Validation**: Testing on independent datasets from different institutions
5. **Clinical Trials**: Prospective studies to validate clinical utility

## Future Directions

Looking forward, we aim to:

- Develop multimodal AI systems that combine histopathology with genomic and clinical data
- Create explainable AI models that enhance pathologist decision-making
- Expand applications to other cancer types and organs
- Establish best practices for clinical deployment of pathology AI
